Clinically Significant Germline Mutations in Cancer-Causing Genes Identified Through Research Studies Should Be Offered to Research Participants by Genetic Counselors
- 20 March 2016
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (9), 898-901
- https://doi.org/10.1200/jco.2015.60.9388
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Return of Individual Research Results and Incidental Findings: Facing the Challenges of Translational ScienceAnnual Review of Genomics and Human Genetics, 2013
- The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer StudyGenetics in Medicine, 2013
- Incidental Variants Are Critical for GenomicsAmerican Journal of Human Genetics, 2013
- Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancerGenetics in Medicine, 2013
- Disclosing pathogenic genetic variants to research participants: Quantifying an emerging ethical responsibilityGenome Research, 2011
- Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test resultsClinical Genetics, 2010
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Offering Individual Genetic Research Results: Context MattersScience Translational Medicine, 2010
- Ethical implications of the use of whole genome methods in medical researchEuropean Journal of Human Genetics, 2009
- Reporting genetic results in research studies: Summary and recommendations of an NHLBI working groupAmerican Journal of Medical Genetics Part A, 2006